Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

Journal of Neurochemistry

Volumn 93, Issue 3, 2005, Pages 762-765

  Rassoulpour, Arash ^a   Wu, Hui Qiu ^a   Ferre, Sergi ^b   Schwarcz, Robert ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

7 nicotinic acetylcholine receptor; Basal ganglia; Glia neuron interactions; Kynurenines; Neurodegenerative diseases; Schizophrenia

Indexed keywords

ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR; CHOLINERGIC RECEPTOR; DOPAMINE; GLUTAMIC ACID; KYNURENIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BASAL GANGLION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; EXTRACELLULAR SPACE; IN VIVO STUDY; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; KYNURENIC ACID; MALE; NANOTECHNOLOGY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18144402868     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03134.x     Document Type: Article

References (31)

1. Alkondon M., Pereira E. F., Cortes W. S., Maelicke A. and Albuquerque E. X. (1997) Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9, 2734-2742.
2. Alkondon M., Pereira E. F., Yu P. et al. (2004) Targeted deletion of the kynurenine aminotransferase II gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J. Neurosci. 24, 4635-4648.
3. Auld D. S. and Robitaille R. (2003) Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron 40, 389-400.
4. Borland L. M. and Michael A. C. (2004) Voltammetric study of the control of striatal dopamine release by glutamate. J. Neurochem. 91, 220-229.
5. Calabresi P., Pisani A., Mercuri N. B. and Bernardi G. (1996) The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19, 19-24.
6. Calabresi P., Centonze D., Gubellini P., Pisani A. and Bernardi G. (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci. 23, 120-126.
7. Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13, 272-276.
8. Carpenedo R., Pittaluga A., Cozzi A., Attucci S., Galli A., Raiteri M. and Moroni F. (2001) Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur. J. Neurosci. 13, 2141-2147.
9. Hilmas C., Pereira E. F., Alkondon M., Rassoulpour A., Schwarcz R. and Albuquerque E. X. (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21, 7463-7473.
10. Kaiser S. and Wonnacott S. (2000) Alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release. Mol. Pharmacol. 58, 312-318.
11. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iversen L. L. and Woodruff G. N. (1988) 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc. Natl Acad. Sci. USA 85, 6547-6550.
12. Kessler M., Terramani T., Lynch G. and Baudry M. (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52, 1319-1328.
13. Krebs M. O., Trovero F., Desban M., Gauchy C., Glowinski J. and Kemel M. L. (1991) Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J. Neurosci. 11, 1256-1262.
14. Kulagina N. V., Zigmond M. J. and Michael A. C. (2001) Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 102, 121-128.
15. Laruelle M., Kegeles L. S. and Abi-Dargham A. (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann. NY Acad. Sci. 1003, 138-158.
16. Lecca D., Shim I., Costa E. and Javaid J. I. (2000) Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats. Neuropharmacology 39, 88-98.
17. Lovinger D. M., Partridge J. G. and Tang K. C. (2003) Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse. Ann. NY Acad. Sci. 1003, 226-240.
18. Marchi M., Risso F., Viola C., Carvazzani P. and Raiteri M. (2002) Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J. Neurochem. 80, 1071-1078.
19. Moroni F., Russi P., Lombardi G., Beni M. and Carlà V. (1988) Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51, 177-180.
20. Papke R. L., Bencherif M. and Lippiello P. (1996) An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci. Lett. 213, 201-204.
21. Parpura V. and Haydon P. G. (2000) Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons. Proc. Natl Acad. Sci. USA 97, 8629-8634.
22. Quarta D., Ferré S., Solinas M., You Z. B., Hockemeyer J., Popoli P. and Goldberg S. R. (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem. 88, 1151-1158.
23. Röver S., Cesura A. M., Huguenin P., Kettler R. and Szente A. (1997) Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl) benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J. Med. Chem. 40, 4378-4385.
24. Salminen O., Murphy K. L., McIntosh J. M., Drago J., Marks M. J., Collins A. C. and Grady S. R. (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol. Pharmacol. 65, 1526-1535.
25. Schwarcz R. and Pellicciari R. (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 303, 1-10.
26. Segovia G., Del Arco A. and Mora F. (1997) Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J. Neurochem. 69, 1476-1483.
27. Sharma G. and Vijayaraghavan S. (2001) Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc. Natl Acad. Sci. USA 98, 4148-4153.
28. Tarazi F. I., Campbell A., Yeghiayan S. K. and Baldessarini R. J. (1998) Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse 30, 227-235.
29. Turski W. A., Nakamura M., Todd W. P., Carpenter B. K., Whetsell W. O. Jr and Schwarcz R. (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 454, 164-169.
30. Westerink B. H., Santiago M. and De Vries J. B. (1992) The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 345, 523-529.
31. Wu H.-Q., Baran H., Ungerstedt U. and Schwarcz R. (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur. J. Neurosci. 4, 1264-1270.